Skip to main content

Commencing Volume 19, Issue 1, MedReviews has ceased the publication of this journal. Reviews in Cardiovascular Medicine will continue to be published by IMRPress, Ltd. (

Volume 1, No 2 - Fall 2000

Table of Contents

Other Contributors to This Issue Other Contributors to This Issue
Update in Cardiac Surgery 31st Annual American College of Cardiology Cardiovascular Conference in Snowmass
On the Horizon in Pacing and Electrophysiology 21st Annual Scientific Sessions of the North American Society of Pacing and Electrophysiology
Evolving Advances in Echocardiography 11th Annual Scientific Sessions of the American Society of Echocardiography
Anorexigen-Related Cardiopulmonary Toxicity Clinical Challenge
Three years after the withdrawal of fenfluramine and dexfenfluramine from the market, the magnitude and prevalence of their deleterious cardiopulmonary effects remain undetermined. The links between these anorexigens and valvular heart disease and primary pulmonary hypertension, however, are clearly established. Because some evidence indicates that the valvular lesions may regress with cessation of the drug, management guidelines are still in flux. Patient reassurance and close surveillance, including serial echocardiography in selected cases, are warranted. [Rev Cardiovasc Med. 2000;1(2):80-89,102]
The Evolving Role of HDL Previews in Cardiovascular Medicine
Risk Assessment of Patients With Known or Suspected CAD Using Stress Myocardial Perfusion SPECT, Part I: The Ongoing Evolution of Clinical Evidence Diagnostic Imaging
In this era of cost containment and evidence-based medicine, validation of a test’s diagnostic ability may be only the beginning step to its acceptance and use. In the imaging world, a test gains cost-effectiveness points if it not only is an independent predictor of outcomes but also adds prognostic information to pretest data. If the test can be used to risk-stratify patients, its value is further enhanced. This review discusses how one of the newer imaging techniques, single-photon emission CT, ranks with regard to the risk assessment of patients with coronary artery disease. [Rev Cardiovasc Med. 2000;1(2):91-102.]
Management of Unstable Angina: Integrating the New Approaches Treatment Update
Great strides have been made in the understanding of unstable angina and its relationship to the acute coronary syndromes and myocardial infarction during the last decade of the 20th century. Detailed information about ECG changes and serum cardiac markers, as well as the conclusions drawn from numerous large, randomized interventional trials can now be integrated into the traditional clinical picture. Clinicians can now classify patients into diagnostic and prognostic categories and can perform risk stratification with unprecedented precision. With this information, the decision to hospitalize patients and the selection of noninvasive or invasive evaluation and management strategies can be individualized for optimal outcomes. [Rev Cardiovasc Med. 2000;1(2):104-119]
Insulin Resistance and Hypertension in the Absence of Subcutaneous Fat Cardiovascular Risk
When a patient presents with insulin resistance, a red flag for cardiovascular risk appears. What is the contribution of visceral fat to this syndrome? What are the risks and benefits of the treatment options for the coexistent cardiovascular risk factors? [Rev Cardiovasc Med. 2000;1(2):120-124]